Restful Robotics is Revolutionizing Sleep Apnea Treatment
Current treatment options are failing.
Restful Robotics is changing this.
Work in progress. Not cleared for sale or use in the US.
Domestic and International patents pending.
Let’s talk about Numbers
1 Billion
adults globally have obstructive sleep apnea
50%
of patients quit therapy
$10 Billion
global market value by 2026
10%
annual market growth for the next 10 years
Untreated Sleep Apnea has Dire Consequences
Obstructive Sleep Apnea causes repeated choking and prevents deep sleep for almost one billion adults globally. When untreated, there are serious related health conditions including stroke, hypertension, atrial fibrillation, diabetes, chronic fatigue, and more.
Traditional Positive Airway Pressure (PAP) therapy, invented over 40 years ago, is still the ‘gold standard’ treatment option and works when used regularly. Unfortunately, over 50% of patients quit therapy, and suffer the long term dire consequences.
Introducing RITA™
The world's first Robot for Improved Therapy Adherence
RITA™ will allow patients to fall asleep free of masks, head straps, and hoses, while still providing PAP therapy
Marketing Advisor
Adam Weintraub
Adam worked at numerous startups and has significant expertise in go-to-market strategy and early commercialization. Former sales / marketing leadership roles at J&J, Medtronic, and Ansell Healthcare.
Technical Advisor
David Mintz
David led R&D Efforts at Auris Health from inception through the acquisition of the company by J&J where he continued on as the VP of R&D for Surgical Robotics. At Auris he participated in raising more than $750M in venture investment, acquiring Hansen Medical, and gaining the initial 510K for Robotic Bronchoscopy. He is now serving as SVP of Product Development at Neptune Medical.
Medical Advisors
Clete Kushida, MD, PhD
Stanford University
Alon Avidan, MD, MPH
UCLA
Andrey Zinchuk, MD, MHS
Yale University
CEO and Cofounder Scott Nortman earned a BS degree in electrical engineering and a MS degree in computer engineering and began his career at Lockheed-Martin's Research Center in Silicon Valley designing space robotics. He then joined MAKO Surgical's R&D group, designing surgical robotic systems. After their acquisition by Stryker, he joined Magic Leap, gaining extensive computer vision experience.
Scott Nortman
Chief Executive Officer
Cofounder
Dr. David Jassir, MD, Chief Clinical Officer and Cofounder, is board certified in Sleep Medicine and Otolaryngology, and currently practices at South Florida ENT Associates. Dr. Jassir graduated from the University of Miami Medical School and completed his residency and fellowship training at University of Miami / Jackson Memorial Hospital in Otolaryngology / Head and Neck Surgery.
David Jassir, MD
Chief Clinical Officer
Cofounder
Cofounders
The Problem with
Traditional PAP Systems
Mask Removal
Many sufferers wake up to find masks pushed aside or removed
Claustrophobia
Many sufferers can not fall asleep wearing masks and head straps
Air Leaks
Tossing and turning cause masks to leak, disrupting therapy
Multiple Revenue Streams
RITA™
Disposables
Sleep Lab Systems
Anonymous Data
